Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Safety and efficacy of Fel d 1 derived peptide...
Conference

Safety and efficacy of Fel d 1 derived peptide immunotherapy in a double-blind, placebo-controlled environmental exposure chamber study

Authors

Larche M; Patel D; Patel P; Salapatek A; Laidler P; Hafner R

Volume

67

Pagination

pp. 90-90

Publisher

WILEY-BLACKWELL

Publication Date

November 1, 2012

Name of conference

31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)

Conference place

Geneva, SWITZERLAND

Conference start date

June 16, 2012

Conference end date

June 20, 2012

Conference proceedings

ALLERGY

ISSN

0105-4538

Labels

Fields of Research (FoR)